Press release
Cardiology Genomic Testing Market Impact Analysis By 2028
Cardiology Genomic Testing Market: Drivers and Restraints
The growing prevalence of heart diseases such as cardiac arrhythmias and atherosclerosis is expected to be the major factor driving the growth of the cardiology genomic testing market over the forecast period. According to Invitae Corporation, more than 1 in 200 people have inherited some form of heart disease. Moreover, unhealthy lifestyle choices increase the risk of heart disease and this factor is driving the cardiology genomic testing market. Cardiology genomic testing helps in diagnosis, prognosis, and management of heart diseases. Cardiology genomic testing helps in identifying patients with a high risk of heart failure or arrhythmias. Also, the test differentiates and confirms the disease from other causes. Cardiology genomic testing also helps in directing treatment options which will avoid trigging cardiac events. Cardiology genomic testing kits provide rapid results and great efficiency. It also helps in reducing risks among patients. However, the number of genes vary with disorders. The overall cardiology genomic market testing is pushed by the growing expenditure on healthcare.
Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2565
Cardiology Genomic Testing Market: Overview
Cardiology genomic testing kits are used as a preventive healthcare diagnostic kit to save the lives of patients. According to the Center for Disease Control and Prevention, approximately 86 million people have at least one type of cardiovascular disease. Cardiology genomic testing kits are easy to use and the results are obtained within 4-8 weeks. The global market for cardiology genomic testing is expected to witness high growth over the forecast period. The cardiology genomic testing market is expected to increase with a rise in cardiac diseases among adults and children. Treatment is necessary for inherited and untreated heart conditions to further prevent serious problems such as heart attacks.
Cardiology Genomic Testing Market: Regional Outlook
Geographically, the global cardiology genomic testing market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). North America is expected to be the dominant market in the global cardiology genomic testing market owing to the increasing number of cardiac diseases. Also, the market in North America will rise due to the advancements in technology as well as strict regulations for patient care and safety in the region. The cardiology genomic testing market in the Asia Pacific excluding Japan is expected to grow at a significant CAGR due to the expansion of product offerings by the key players. In addition, cardiology genomic testing is contributing to the improvement of the health of the population by decreasing heart attack and congenital heart disease rates. Europe is expected to have the second largest share in the global cardiology genomic testing market throughout the forecast period.
Request for table of content on this report visit:https://www.factmr.com/connectus/sample?flag=T&rep_id=2565
Cardiology Genomic Testing Market: Key Players
The global market for cardiology genomic testing is highly fragmented. Examples of some of the key players operating in cardiology genomic testing kits are Color Genomics, Inc. Thermo Fisher Scientific, Admera Health, Helix OpCo LLC, Blueprint Genetics Oy. Illumina, Inc., Gnome Diagnostics, Creative Diagnostics, Merck KGaA, MP Biomedicals, LLC., CENTOGENE AG, and Oasis Diagnostics Corporation among others.
For more information on this report, please visit:https://www.factmr.com/report/2565/cardiology-genomic-testing-market
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Read Industrial News : http://insiderstribune.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardiology Genomic Testing Market Impact Analysis By 2028 here
News-ID: 1606795 • Views: 512
More Releases from Fact.MR
UV Booster Utilization Is Anticipated To Grow At A CAGR Of 5.1% By 2033
The global market for UV boosters is predicted to reach US$ 121.5 million in 2023 by the latest analysis from Fact.MR, and it is anticipated to expand at a CAGR of 5.1% from 2022 to 2033.
In order to lower their chance of being exposed to dangerous UV rays, consumers around the world are demanding cosmetic products with high SPF. UV boosters, commonly referred to as SPF boosters, have gained popularity…
Teeth Whitening Strip Sales Are Projected To Reach US$ 212 Million By 2032
The expected CAGR for the global consumption of teeth-whitening strips is 9.8% from 2022 to 2032. The market for teeth whitening strips is presently valued at US$ 83.7 million, and by the end of 2032, it is expected to have grown to US$ 212 million.
Global demand for dental hygiene products has grown as a result of growing urbanisation and an increased emphasis on personal care. Teeth whitening products are quite…
Sales of Dairy Enzymes Is Slated to Expand at Around 8% CAGR by 2033
The global market for dairy enzymes is poised to witness strong growth until 2033, expanding more than 2x. As of 2023, the market is anticipated to be valued at approximately US$ 700 Mn. Applications for cheese production is slated to emerge dominant, resulting in sales worth US$ 150 Mn in the previous year and expanding at a CAGR of 7% until 2033.
Increasing prevalence of diseases across the globe is generating…
Demand for Trade Finance Is Expected to Expand at A CAGR of 4.5% By 2033
Trading intermediates, such as banks and other financial organisations, support various transactions between buyers and sellers in trade finance, which is the financing of domestic and international trade flows. The risk associated with both local and international trade financing is reduced through trade finance. One of the reasons why global trade has grown so significantly over time is trade finance.
With thorough market research, companies may realise their full potential. Businesses…
More Releases for Cardiology
Cardiology Conference 2022
Theme: "Exploring New Research and Frontiers in Heart Care"
Heart 2022 welcomes all the eminent professional scholars, researchers and beloved students to be a part of this “INTERNATIONAL CONFERENCE ON CLINICAL CARDIOLOGY & CONGENITAL HEART DISEASE” scheduled on FEBRUARY 07-08, 2022 | PARIS | FRANCE. With individuals from around the world zeroed in on finding a few solutions concerning Cardiology, this is your single most clear chance to achieve the best…
World Cardiology Congress
Herald Meetings welcomes you to join World Cardiology Congress scientific symposium will be held in Prague, Czech Republic during August 26 to 27, 2020
About Conferences:
WORLD CARDIOLOGY CONGRESS, scheduled on August 26-27, 2020 at Prague, Czech Republic. The conference strives to provide meaningful coverage on the theme "Prediction, Prevention and Cure of Cardiovascular Diseases".
Cardiology Congress has established itself as a significant forum for Professors, Cardiology Specialists, Eminent Scientists, and Vascular surgeons,…
25th World Cardiology Conference
Conference series proudly announces the “25th World Cardiology Conference” which will be held during July 10-11, 2019 at Osaka, Japan. The theme of conference is “New Insights in Cardiology for a diverse World”. Cardiology Congress 2019 Conference will be an investigation of new research Innovation in the field of Cardiology and spread the most recent advancements in heart disease prevention and rehabilitation. Discussion on new technology advancement in the field…
Cardiology Surgery, Devices and Drugs Market Report 2018: Segmentation by Type ( …
Global Cardiology Surgery, Devices and Drugs market research report provides company profile for St. Jude Medical, Cook Medical, C. R. Bard, Sun Pharmaceutical, Pfizer, Sanofi, AstraZeneca, Novartis, Bristol-Myers Squibb, Merck, Boston Scientific, Medtronic and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and…
27th European Cardiology Conference
27th European Cardiology Conference
Details:
With the successful completion of 20th European Cardiology Conference, the Cardiology Conferences in 2018 meet is proud to announce that its 3 day 27th European Cardiology Conference (Euro Cardiology 2018) will be held in Rome, Italy during October 22-24, 2018.The conference will be the world’s best platform for all the cardiologists, cardiac surgeons, medical practitioners, research scholars and clinical research organizations to encourage and explore the modern…
19th Annual Cardiology
19th Annual Cardiology Conference to be held in Philadelphia, USA during August 31-September 1, 2017 Annual Cardiology 2017 will bring together world-class cardiac professors, cardiac surgeons, cardiologists to discuss strategies for remediation of the disease for the heart, cardiac disorders, research on stem cells in cardiology, cardiac enzyme studies. Cardiology conferences are designed to provide a diversified education and present that will keep medical professionals informed of issues related to…
